Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action
{{output}}
Nonalcoholic fatty liver disease, recently termed metabolic dysfunction-associated steatotic liver disease, affects 25% of adults globally, with a prevalence reaching 93% in obese individuals. The MANPOWER study, a post hoc analysis of 2843 Russian patients wi... ...
